Literature DB >> 10375226

Postmortem proteolysis and calpain/calpastatin activity in callipyge and normal lamb biceps femoris during extended postmortem storage.

G H Geesink1, M Koohmaraie.   

Abstract

The present experiment was conducted to determine whether calpastatin inhibits only the rate, or both the rate and extent, of calpain-induced postmortem proteolysis. Biceps femoris from normal (n = 6) and callipyge (n = 6) lamb was stored for 56 d at 4 degrees C. Calpastatin activity was higher (P < .05) in the callipyge muscle at 0 and 14 d postmortem, but not at 56 d postmortem. The activity of mu-calpain did not differ between normal and callipyge biceps femoris at 0 and 56 d postmortem (P > .05), but was higher at 14 d postmortem in the callipyge muscle (P < 0.05). The activity of m-calpain was higher in the callipyge muscle (P < 0.05). Western blot analyses of titin, nebulin, dystrophin, myosin heavy chain, vinculin, alpha-actinin, desmin, and troponin-T indicated that postmortem proteolysis was less extensive in callipyge than in normal biceps femoris at all postmortem times. The results of this experiment indicate that calpastatin inhibits both the rate and extent of postmortem proteolysis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10375226     DOI: 10.2527/1999.7761490x

Source DB:  PubMed          Journal:  J Anim Sci        ISSN: 0021-8812            Impact factor:   3.159


  12 in total

1.  Postmortem degradation of skeletal muscle proteins: a novel approach to determine the time since death.

Authors:  Stefan Pittner; Fabio C Monticelli; Alexander Pfisterer; Angela Zissler; Alexandra M Sänger; Walter Stoiber; Peter Steinbacher
Journal:  Int J Legal Med       Date:  2015-06-04       Impact factor: 2.686

2.  Skeletal muscle proteins: a new approach to delimitate the time since death.

Authors:  Elena Esra Foditsch; Alexandra Maria Saenger; Fabio Carlo Monticelli
Journal:  Int J Legal Med       Date:  2015-06-02       Impact factor: 2.686

3.  Determining time of death: temperature-dependent postmortem changes in calcineurin A, MARCKS, CaMKII, and protein phosphatase 2A in mouse.

Authors:  Yekaterina O Poloz; Danton H O'Day
Journal:  Int J Legal Med       Date:  2009-03-27       Impact factor: 2.686

4.  Dismembered porcine limbs as a proxy for postmortem muscle protein degradation.

Authors:  J Geissenberger; B Ehrenfellner; F C Monticelli; Stefan Pittner; Peter Steinbacher
Journal:  Int J Legal Med       Date:  2021-05-06       Impact factor: 2.686

5.  A defect in dystrophin causes a novel porcine stress syndrome.

Authors:  Dan J Nonneman; Tami Brown-Brandl; Shuna A Jones; Ralph T Wiedmann; Gary A Rohrer
Journal:  BMC Genomics       Date:  2012-06-12       Impact factor: 3.969

6.  Postmortem muscle protein degradation in humans as a tool for PMI delimitation.

Authors:  Stefan Pittner; Bianca Ehrenfellner; Fabio C Monticelli; Angela Zissler; Alexandra M Sänger; Walter Stoiber; Peter Steinbacher
Journal:  Int J Legal Med       Date:  2016-03-07       Impact factor: 2.686

7.  Does altered protein metabolism interfere with postmortem degradation analysis for PMI estimation?

Authors:  A Zissler; B Ehrenfellner; E E Foditsch; F C Monticelli; S Pittner
Journal:  Int J Legal Med       Date:  2018-03-02       Impact factor: 2.686

8.  Postmortem proteomics to discover biomarkers for forensic PMI estimation.

Authors:  Kyoung-Min Choi; Angela Zissler; Eunjung Kim; Bianca Ehrenfellner; Eunji Cho; Se-In Lee; Peter Steinbacher; Ki Na Yun; Jong Hwan Shin; Jin Young Kim; Walter Stoiber; Heesun Chung; Fabio Carlo Monticelli; Jae-Young Kim; Stefan Pittner
Journal:  Int J Legal Med       Date:  2019-03-12       Impact factor: 2.686

Review 9.  Postmortem Protein Degradation as a Tool to Estimate the PMI: A Systematic Review.

Authors:  Angela Zissler; Walter Stoiber; Peter Steinbacher; Janine Geissenberger; Fabio C Monticelli; Stefan Pittner
Journal:  Diagnostics (Basel)       Date:  2020-11-26

10.  Are animal models predictive for human postmortem muscle protein degradation?

Authors:  Bianca Ehrenfellner; Angela Zissler; Peter Steinbacher; Fabio C Monticelli; Stefan Pittner
Journal:  Int J Legal Med       Date:  2017-07-18       Impact factor: 2.686

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.